ZA200807263B - Novel heteroaryl-substituted arylaminopyrldine derivatives as MEK inhibitors - Google Patents

Novel heteroaryl-substituted arylaminopyrldine derivatives as MEK inhibitors

Info

Publication number
ZA200807263B
ZA200807263B ZA200807263A ZA200807263A ZA200807263B ZA 200807263 B ZA200807263 B ZA 200807263B ZA 200807263 A ZA200807263 A ZA 200807263A ZA 200807263 A ZA200807263 A ZA 200807263A ZA 200807263 B ZA200807263 B ZA 200807263B
Authority
ZA
South Africa
Prior art keywords
arylaminopyrldine
derivatives
substituted
mek inhibitors
novel heteroaryl
Prior art date
Application number
ZA200807263A
Other languages
English (en)
Inventor
Goutopoulos Andreas
Jr Benny C Askew
Chen Xiaoling
Karra Srinivasa
Yu Henry
Original Assignee
Serono Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Serono Lab filed Critical Serono Lab
Publication of ZA200807263B publication Critical patent/ZA200807263B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/79—Acids; Esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
ZA200807263A 2006-04-19 2007-04-18 Novel heteroaryl-substituted arylaminopyrldine derivatives as MEK inhibitors ZA200807263B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US79307306P 2006-04-19 2006-04-19

Publications (1)

Publication Number Publication Date
ZA200807263B true ZA200807263B (en) 2009-11-25

Family

ID=38357968

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200807263A ZA200807263B (en) 2006-04-19 2007-04-18 Novel heteroaryl-substituted arylaminopyrldine derivatives as MEK inhibitors

Country Status (15)

Country Link
US (1) US8076486B2 (fr)
EP (1) EP2013180A1 (fr)
JP (1) JP5525812B2 (fr)
KR (1) KR20090005195A (fr)
CN (2) CN101426766B (fr)
AR (1) AR060807A1 (fr)
AU (1) AU2007240860A1 (fr)
BR (1) BRPI0711625A2 (fr)
CA (1) CA2644425A1 (fr)
EA (1) EA200802050A1 (fr)
HK (1) HK1127354A1 (fr)
IL (1) IL194546A0 (fr)
MX (1) MX2008013308A (fr)
WO (1) WO2007123936A1 (fr)
ZA (1) ZA200807263B (fr)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2007123939A2 (fr) * 2006-04-19 2007-11-01 Laboratoires Serono S.A. Nouveaux arylamino n-hétéraryles en tant qu'inhibiteurs de mek
BRPI0821151A2 (pt) * 2007-12-07 2015-06-16 Novartis Ag Derivados de pirazol e uso dos mesmos como inibidores de quinases dependentes de ciclina
JP5651125B2 (ja) 2008-12-10 2015-01-07 デイナ ファーバー キャンサー インスティチュート，インコーポレイテッド Ｍｅｋ阻害剤に対する耐性を付与するｍｅｋ突然変異
RU2571930C2 (ru) 2010-02-25 2015-12-27 Дана-Фарбер Кэнсер Инститьют, Инк. Мутации braf, обеспечивающие резистентность к ингибиторам braf
CN103038364A (zh) 2010-03-09 2013-04-10 达纳－法伯癌症研究所公司 诊断和治疗具有或发展对于第一种癌症治疗的抗性的患者中的癌症的方法
EP2560488B1 (fr) 2010-04-23 2015-10-28 Cytokinetics, Inc. Aminopyridines et aminotriazines, leurs compositions et leurs procédés d'utilisation
AR081331A1 (es) 2010-04-23 2012-08-08 Cytokinetics Inc Amino- pirimidinas composiciones de las mismas y metodos para el uso de los mismos
AR081626A1 (es) 2010-04-23 2012-10-10 Cytokinetics Inc Compuestos amino-piridazinicos, composiciones farmaceuticas que los contienen y uso de los mismos para tratar trastornos musculares cardiacos y esqueleticos
US8759380B2 (en) 2011-04-22 2014-06-24 Cytokinetics, Inc. Certain heterocycles, compositions thereof, and methods for their use
WO2013169858A1 (fr) 2012-05-08 2013-11-14 The Broad Institute, Inc. Méthodes de diagnostic et de traitement chez des patients ayant ou présentant un risque de développer une résistance à une thérapie anticancéreuse
US9630976B2 (en) * 2012-07-03 2017-04-25 Ono Pharmaceutical Co., Ltd. Compound having agonistic activity on somatostatin receptor, and use thereof for medical purposes
CN107427497A (zh) * 2015-03-10 2017-12-01 奥瑞基尼探索技术有限公司 作为免疫调节剂的3‑取代的1,3,4‑噁二唑和噻二唑化合物
US9573936B2 (en) 2015-05-20 2017-02-21 Amgen Inc. Triazole agonists of the APJ receptor
US20190008859A1 (en) 2015-08-21 2019-01-10 Acerta Pharma B.V. Therapeutic Combinations of a MEK Inhibitor and a BTK Inhibitor
US10150754B2 (en) 2016-04-19 2018-12-11 Celgene Quanticel Research, Inc. Histone demethylase inhibitors
US9988369B2 (en) 2016-05-03 2018-06-05 Amgen Inc. Heterocyclic triazole compounds as agonists of the APJ receptor
WO2018093580A1 (fr) 2016-11-16 2018-05-24 Amgen Inc. Composés de triazole pyridyle en tant qu'agonistes du récepteur apj
EP3541805B1 (fr) 2016-11-16 2020-10-14 Amgen Inc. Triazoles substitués par hétéroaryle utilisés en tant qu'agonistes du récepteur apj
WO2018097944A1 (fr) 2016-11-16 2018-05-31 Amgen Inc. Composés de triazole furane utilisés en tant qu'agonistes du récepteur apj
MA46824A (fr) 2016-11-16 2019-09-25 Amgen Inc Composés de triazole substitués par alkyle en tant qu'agonistes du récepteur apj
EP3541804A1 (fr) 2016-11-16 2019-09-25 Amgen Inc. Composés de triazole à substitution cycloalkyle en tant qu'agonistes du récepteur apj
WO2018093579A1 (fr) 2016-11-16 2018-05-24 Amgen Inc. Composés phényle triazole en tant qu'agonistes du récepteur apj
CA3062294A1 (fr) 2017-05-03 2018-11-08 Vivace Therapeutics, Inc. Composes tricycliques non fusionnes
US11192865B2 (en) 2017-08-21 2021-12-07 Vivace Therapeutics, Inc. Benzosulfonyl compounds
EP3704122B1 (fr) 2017-11-03 2021-09-01 Amgen Inc. Agonistes de triazole fusionnés du récepteur apj
EP3720430A4 (fr) 2017-12-06 2021-05-05 Vivace Therapeutics, Inc. Composés benzocarbonyle
JP7292299B2 (ja) * 2017-12-07 2023-06-16 アンプリックス ファーマシューティカルズ，インク． 複素環式の置換ピリジン誘導体である抗真菌薬
CN110317190A (zh) * 2018-03-28 2019-10-11 首都医科大学 一种***-羧酸酯类衍生物在医药领域的应用
WO2019213006A1 (fr) 2018-05-01 2019-11-07 Amgen Inc. Pyrimidinones substituées en tant qu'agonistes du récepteur apj
US11661403B2 (en) 2018-05-16 2023-05-30 Vivace Therapeutics, Inc. Oxadiazole compounds
EP3942045A1 (fr) 2019-03-21 2022-01-26 Onxeo Molécule dbait associée à un inhibiteur de kinase pour le traitement du cancer
EP4054579A1 (fr) 2019-11-08 2022-09-14 Institut National de la Santé et de la Recherche Médicale (INSERM) Méthodes pour le traitement de cancers qui ont acquis une résistance aux inhibiteurs de kinase
EP4061364A4 (fr) * 2019-11-20 2023-09-13 Vivace Therapeutics, Inc. Composés hétéroaryles
WO2021148581A1 (fr) 2020-01-22 2021-07-29 Onxeo Nouvelle molécule dbait et son utilisation

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20010108093A (ko) 1999-01-13 2001-12-07 로즈 암스트롱, 크리스틴 에이. 트러트웨인 1-헤테로고리 치환된 디아릴아민
GB2373245A (en) * 2001-03-12 2002-09-18 Bayer Ag Pyridinyl pyrazoles and their use for the treatment of COPD
WO2004024711A1 (fr) 2002-09-10 2004-03-25 Pharmacia Italia S.P.A. Derives de pyridine substitues utilises comme agent antitumoral
WO2004052280A2 (fr) 2002-12-10 2004-06-24 Imclone Systems Incorporated Composes anti-angiogenique et utilisations de ceux-ci dans le traitement du cancer
US20050004186A1 (en) * 2002-12-20 2005-01-06 Pfizer Inc MEK inhibiting compounds
JP4881725B2 (ja) * 2003-04-09 2012-02-22 エクセリクシス， インク． Ｔｉｅ−２モジュレータと使用方法
WO2005000818A1 (fr) 2003-06-27 2005-01-06 Warner-Lambert Company Llc Derives de 4-[phenylamino (substitue)]-2-pyridone a substitution en 5 en tant qu'inhibiteurs de la mek
WO2005004818A2 (fr) * 2003-07-09 2005-01-20 Imclone Systems Incorporated Composes heterocycliques et leur utilisation comme agents anticancereux
DE602004031037D1 (de) 2003-11-19 2011-02-24 Array Biopharma Inc Heterocyclische inhibitoren von mek
EA013212B1 (ru) * 2004-10-20 2010-04-30 Лаборатуар Сероно Са 3-ариламинопиридиновые производные

Also Published As

Publication number Publication date
BRPI0711625A2 (pt) 2011-12-06
JP2009534386A (ja) 2009-09-24
CN101426766A (zh) 2009-05-06
US20070287737A1 (en) 2007-12-13
CA2644425A1 (fr) 2007-11-01
CN101426766B (zh) 2014-03-26
AU2007240860A1 (en) 2007-11-01
CN103121996B (zh) 2015-10-21
HK1127354A1 (en) 2009-09-25
KR20090005195A (ko) 2009-01-12
WO2007123936A1 (fr) 2007-11-01
MX2008013308A (es) 2008-10-27
IL194546A0 (en) 2009-08-03
AR060807A1 (es) 2008-07-16
JP5525812B2 (ja) 2014-06-18
EA200802050A1 (ru) 2009-04-28
CN103121996A (zh) 2013-05-29
US8076486B2 (en) 2011-12-13
EP2013180A1 (fr) 2009-01-14

Similar Documents

Publication Publication Date Title
ZA200807263B (en) Novel heteroaryl-substituted arylaminopyrldine derivatives as MEK inhibitors
ZA200807447B (en) Thieno-Pyridine derivatives as MEK inhibitors
ZA200707650B (en) Azolylacylguanidines as ß-secretase inhibitors
IL198247A0 (en) Indazole derivatives useful as l-cpt1 inhibitors
IL192634A0 (en) Thiazoles as 11 beta-hsd1 inhibitors
HK1143367A1 (en) Quinazolin-oxime derivatives as hsp90 inhibitors hsp90 -
HK1105592A1 (en) Aryl-pyridine derivatives as 1-beta-hsd1 inhibitors
PL2102205T3 (pl) Pochodne pirydopirazyny użyteczne jako związki chwastobójcze
HK1107348A1 (en) Indozolone derivatives as 11b-hsd1 inhibitors
SI2383271T1 (sl) Aminokinoloni kot inhibitorji gsk-3
IL200047A0 (en) Pyrazole derivatives as 11-beta-hsd1 inhibitors
IL195158A0 (en) Novel heterocyclic compounds
ZA200809800B (en) 2-Thioxanthine derivatives acting as Mpo-inhibitors
IL196000A0 (en) 2-arylindole derivatives as npges-i inhibitors
GB0622472D0 (en) Novel heterocyclic derivatives
IL196807A0 (en) Inhibitors for glyt-1
GB0614154D0 (en) Novel Pyriazine Derivatives
ZA200905235B (en) Pyrazole derivatives as 11-beta-hsd1 inhibitors
ZA200710338B (en) Oxydiazole derivatives as DGAT inhibitors
ZA200809385B (en) Novel heterocyclic compounds
GB0618472D0 (en) Prior art tracker
GB0707632D0 (en) Novel inhibitors
GB0707499D0 (en) Novel inhibitors
GB0704589D0 (en) Novel inhibitors
GB0707488D0 (en) Novel inhibitors